Cargando…
Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma via Inducing miR-25-5p Expression by Directly Targeting NEDD9
Melatonin exerts anti-cancer roles in various types of cancers. However, to the best of our knowledge, its role in oral squamous cell carcinoma (OSCC) is unknown. The present study aimed to investigate the role of melatonin and its underlying mechanism in OSCC. MTT, colony formation, wound healing,...
Autores principales: | Wang, Yanling, Tao, Bo, Li, Jiaying, Mao, Xiaoqun, He, Wei, Chen, Qinbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738623/ https://www.ncbi.nlm.nih.gov/pubmed/33344223 http://dx.doi.org/10.3389/fonc.2020.543591 |
Ejemplares similares
-
NEDD9 Inhibition by miR-25-5p Activation Is Critically Involved in Co-Treatment of Melatonin- and Pterostilbene-Induced Apoptosis in Colorectal Cancer Cells
por: Jung, Ji Hoon, et al.
Publicado: (2019) -
NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma
por: Grauzam, Stéphane, et al.
Publicado: (2018) -
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012) -
Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25
por: Wang, Xueping, et al.
Publicado: (2021) -
miR-107 is involved in the regulation of NEDD9-mediated invasion and metastasis in breast cancer
por: Zhou, Jiamin, et al.
Publicado: (2022)